RZLT
NASDAQ
$4.45
Rezolute Inc (RZLT)
Rezolute, Inc., a clinical-stage biopharmaceutical company, develops rare and metabolic disease therapies in the United States. The company is headquartered in Redwood City, California.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $7.67 (+72.36%)
Market Cap
$456M
Free Cash Flow Yield
-16.11%
Beta (5Y)
0.95
Price Chart
Valuation
Market Cap$456M
P/B3.98
Profitability
EBITDA-$133M
EPS-$1.46
Financial Health
Free Cash Flow Yield-16.11%
Growth & Risk
EPS 5Y CAGR-10.29%
Beta (5Y)0.95
Sharpe Ratio1.05